These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5697768)

  • 1. [Platelet adhesiveness and drip rate during extracorporeal dialysis in uremia].
    Cortellaro M; Brancaccio D
    Haematol Lat; 1968; 11(2):189-97. PubMed ID: 5697768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activation of blood platelets and the plasma coagulation system in patients with chronic uremia].
    Dmoszyńska-Giannopoulou A; Ksiazek A; Baran E; Pachucki Z
    Pol Tyg Lek; 1987 Jul; 42(30):915-7. PubMed ID: 3671183
    [No Abstract]   [Full Text] [Related]  

  • 4. The first 15 minutes of hemodialysis does not affect platelets.
    Komarnicki M; Kaźmierczak M; de Mezer-Dambek M
    Haematologia (Budap); 1996; 28(1):41-4. PubMed ID: 9283903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modification of uremic thrombocytopathy by hemodialysis].
    Frick U; Frick G; Vitu J; Wiedenhöft I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hemodialysis on platelet adhesiveness.
    Evansho J; Greco M
    Am J Med Technol; 1974 Jan; 40(1):9-16. PubMed ID: 4813119
    [No Abstract]   [Full Text] [Related]  

  • 7. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Periodic hemodialysis in non-selected patients with chronic terminal uremia. Results of a study made in a Northeastern Lombardia District Hospital with special regard to survival and influence of age (1573 cases of extracorporeal dialysis in 22 patients)].
    Gargano N
    Minerva Med; 1973 Sep; 64(63):3283-91. PubMed ID: 4774224
    [No Abstract]   [Full Text] [Related]  

  • 9. The blood platelet proteome is changed in UREMIC patients.
    Walkowiak B; Kaminska M; Okrój W; Tanski W; Sobol A; Zbróg Z; Przybyszewska-Doros I
    Platelets; 2007 Aug; 18(5):386-8. PubMed ID: 17654309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia of uremia responsive to increased dialysis treatment.
    Lindholm DD; Pace RL; Russell HH
    Trans Am Soc Artif Intern Organs; 1969; 15():360-6. PubMed ID: 5791410
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of uremia and hemodialysis on platelet apoptosis.
    Sobol AB; Kaminska M; Walczynska M; Walkowiak B
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):320-3. PubMed ID: 22387580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
    Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
    Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet dysfunction and its life span in uremia.
    Tanaka H; Uminoto K; Izumi N; Nishimoto K; Yoshihara H; Katoh Y; Kishimuto T; Maekawa M
    Trans Am Soc Artif Intern Organs; 1984; 30():207-10. PubMed ID: 6442804
    [No Abstract]   [Full Text] [Related]  

  • 15. The spreading ability of platelets in chronic uraemia.
    Berkessy S; Faludi AG
    Ann Clin Res; 1974 Feb; 6(1):65-7. PubMed ID: 4544909
    [No Abstract]   [Full Text] [Related]  

  • 16. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
    Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
    Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in serum profile of medium molecules in patients treated with dialysis for various lengths of time].
    Manari A; Buzio C; Calderini C; David S; Montagna G; Quaretti P; Gröf J; Migone L
    Minerva Nefrol; 1982; 29(2):93-100. PubMed ID: 7133545
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
    Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
    Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].
    Birkeland SA; Hoffmeyer J; Rojel J
    Ugeskr Laeger; 1969 Mar; 131(12):511-9. PubMed ID: 5793607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.